Medication info

Acyclovir Suspension

Prescription medicationExpired
Ingredient · strength
Acyclovir›Strength being verified
Manufacturer / importer
Teragen Etex Co., Ltd.
Appearance
Red suspension with strawberry flavor
Packaging
1 bottle X 100 milliliters
Approval status
Expired

MFDS item code 200201975 · Notified 2002.10.04

This product's status changed to Expired on 2023.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of chickenpox in children aged 2 years and older, treatment and prevention of herpes simplex, and treatment of shingles
Who uses it
Adults · Children
Adult dosage
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer 200 mg of acyclovir per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended for severe initial infections. 2) In patients with severe immunodeficiency (such as after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection. For recurrent infections, treatment should preferably begin at the first sign of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg of this medicine 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, long-term treatment should be interrupted periodically every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg of this medicine 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunodeficiency (such as after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this medicine per dose 5 times daily at approximately 4-hour intervals, except during sleeping hours, for a total of 7 days. 2) Intravenous administration should be considered for patients with severe immunodeficiency or gastrointestinal malabsorption. 3) It is best to start treatment as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more likely to experience adverse reactions affecting the central nervous system, so use caution, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount accumulated with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL/minute), it is preferable to administer 200 mg of this medicine every 12 hours. 2. Treatment of herpes zoster virus infections 1) For patients with creatinine clearance less than 10 mL/minute, it is preferable to reduce the dose to 800 mg of this medicine twice daily at approximately 12-hour intervals. 2) For patients with creatinine clearance of 10 ~ 25 mL/minute, it is preferable to reduce the dose to 800 mg of this medicine 3 times daily at approximately 8-hour intervals.
Children's dosage
○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients 1) Age 2 years and older: Same as the adult dose. 2) Under 2 years: Administer 1/2 of the adult dose. 3) There are currently no definitive data on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children aged 2 years and older: Administer 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment should begin as soon as possible after the chickenpox rash appears, preferably within 24 hours of rash onset.

Ingredients

Manufacturer
Teragen Etex Co., Ltd.

Efficacy & effects

Treatment of chickenpox in children aged 2 years and older, treatment and prevention of herpes simplex, and treatment of shingles

  • Genital herpes
  • herpes simplex virus infection of skin and mucous membranes
  • shingles virus infection
  • acute pain
  • chickenpox
View approved original text

This medication is used for the treatment and prevention of herpes simplex virus infections, including primary and recurrent genital herpes, as well as herpes infections of the skin and mucous membranes. It is particularly effective in relieving acute pain associated with shingles virus infections. However, the efficacy for postherpetic neuralgia is not yet proven. This medication is also used in children over 2 years of age for the treatment of chickenpox. Therefore, it is useful for improving and treating symptoms of various herpes virus infections.

Dosage and Administration

Adult dosage

○ Adults 1. Treatment of herpes simplex virus infections 1) Administer 200 mg of acyclovir per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended for severe initial infections. 2) In patients with severe immunodeficiency (such as after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection. For recurrent infections, treatment should preferably begin at the first sign of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg of this medicine 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, long-term treatment should be interrupted periodically every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg of this medicine 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunodeficiency (such as after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this medicine per dose 5 times daily at approximately 4-hour intervals, except during sleeping hours, for a total of 7 days. 2) Intravenous administration should be considered for patients with severe immunodeficiency or gastrointestinal malabsorption. 3) It is best to start treatment as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more likely to experience adverse reactions affecting the central nervous system, so use caution, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount accumulated with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL/minute), it is preferable to administer 200 mg of this medicine every 12 hours. 2. Treatment of herpes zoster virus infections 1) For patients with creatinine clearance less than 10 mL/minute, it is preferable to reduce the dose to 800 mg of this medicine twice daily at approximately 12-hour intervals. 2) For patients with creatinine clearance of 10 ~ 25 mL/minute, it is preferable to reduce the dose to 800 mg of this medicine 3 times daily at approximately 8-hour intervals.

Children's dosage

○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients 1) Age 2 years and older: Same as the adult dose. 2) Under 2 years: Administer 1/2 of the adult dose. 3) There are currently no definitive data on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children aged 2 years and older: Administer 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment should begin as soon as possible after the chickenpox rash appears, preferably within 24 hours of rash onset.

Precautions

This medication should not be used in patients who are allergic to this drug or its components, or to valacyclovir. Caution is advised in patients with impaired kidney function as they may be at risk of neurological symptoms. In patients with decreased liver function, care should be taken as liver function may worsen. In infants and children, it should be administered cautiously, particularly in newborns and low-birth-weight infants, as the safety of this medication has not been established, and it should only be used when necessary. Elderly patients are likely to have decreased kidney function, leading to higher drug concentrations and increased risk of adverse reactions, so dosage and administration intervals should be adjusted, and adequate hydration is necessary. During administration of this drug, serious allergic reactions such as shock or anaphylaxis can rarely occur, so symptoms should be closely monitored. If symptoms like low blood pressure, difficulty breathing, or chest tightness occur, administration should be stopped immediately and appropriate treatment sought. Photosensitivity, skin rash, fever, vesicles, and hives can occur, so if these symptoms arise, administration should be stopped and a physician consulted. Skin-related side effects can include hair loss, severe skin inflammation, Stevens-Johnson syndrome, and Lyell syndrome, so the condition of the skin should be closely monitored. Neurological side effects may include altered consciousness, confusion, hallucinations, seizures, drowsiness, anxiety, and movement disorders, particularly in elderly patients or those with renal impairment. Side effects affecting kidney function may include renal failure, hematuria, and proteinuria, so urine status and kidney function should be periodically checked. Blood and lymphatic system abnormalities may present as leukopenia, bleeding, and anemia, necessitating blood tests for monitoring. Symptoms of liver dysfunction can include hepatitis, jaundice, and elevated liver function tests, so liver function should be regularly monitored. Gastrointestinal side effects may include gastritis, nausea, vomiting, diarrhea, and abdominal pain, so if gastrointestinal symptoms are severe, medical personnel should be notified immediately. General symptoms may include fever, muscle weakness, and headache, so overall health should be well-monitored. Musculoskeletal symptoms may result in joint pain or muscle aches, so if discomfort persists, consultation with a physician is necessary. Cardiovascular side effects may result in arrhythmias, blood pressure changes, and chest pain, so cardiac-related symptoms should be closely observed. Rarely, urinary issues such as urinary obstruction or difficulty urinating may occur, so if there are problems with urination, it should be reported. If symptoms do not improve within a certain period after starting therapy, alternative treatment methods may need to be considered. Particularly for shingles, administration should commence within 5 days of the onset of skin symptoms; for chickenpox, within 3 days is most effective. In patients with compromised immune function, intravenous formulations should be considered, and adequate hydration should be maintained throughout treatment to reduce the risks of dehydration and renal toxicity. In treating recurrent genital herpes, treatment should be reviewed after 1 year to determine whether to continue. This medication may cause altered states of consciousness, so caution is required when driving or operating machinery, particularly in patients with reduced kidney function. Interactions may occur with other medications, especially those affecting kidney function or specific drugs, so consultation with a physician or pharmacist is advised when co-administered. Pregnant women or those who may become pregnant should carefully weigh the benefits and risks when using this medication, and breastfeeding should be discontinued as the components may pass into breast milk. Overdose may lead to severe neurological symptoms and kidney damage; if overdose is suspected, immediate medical attention should be sought.

Side effects

  • Anaphylactic shock
  • anaphylactoid reaction
  • hypotension
  • shortness of breath
  • chest tightness
  • photosensitivity reaction
  • fixed drug eruption
  • rash
  • fever
  • blisters
Show 118 more
  • urticaria-like erythema
  • urticaria
  • alopecia
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • concentration difficulties
  • aggressive behavior
  • depersonalization
  • anxiety
  • ataxia
  • coma
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucinations
  • psychosis
  • seizures
  • drowsiness
  • tremors
  • excitement
  • forgetfulness
  • insomnia
  • anxiety
  • talking to oneself
  • paresthesia
  • ataxia
  • inability to walk
  • involuntary movements
  • nystagmus
  • dizziness
  • renal failure
  • crystalluria
  • elevated BUN
  • elevated serum creatinine
  • hematuria
  • proteinuria
  • urinary red blood cell casts
  • pyuria
  • leukocytoclastic vasculitis
  • lymphadenopathy
  • bleeding
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • granulocytopenia
  • thrombocytopenia
  • basophilia
  • hepatitis
  • liver dysfunction
  • jaundice
  • abnormal liver function tests
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • loose stools
  • epigastric pain
  • stomach pain
  • abdominal pain
  • nausea
  • vomiting
  • dyspepsia
  • loss of appetite
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • fatigue
  • generalized malaise
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • hypertension
  • hypotension
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glucosuria
  • pneumonia
  • pharyngitis
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • taste disorders
  • hair loss
  • sweating
  • hyponatremia
  • decreased serum protein
  • elevated total cholesterol levels
  • elevated triglyceride levels
  • elevated serum potassium levels
  • decreased serum albumin levels
  • anxiety
  • coma
  • seizures
  • somnolence
  • confusion
  • hallucinations
  • excitement
  • seizure disorders
  • comatose state

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture ingress. It is advisable to store at room temperature, between 1 and 30 degrees Celsius, avoiding extreme heat or cold.

Appearance and packaging

Appearance

Red suspension with strawberry flavor

Package unit

1 bottle X 100 milliliters

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.